Geranium oil (GO) has antiproliferative, antiangiogenic,
and anti-inflammatory
properties. Ascorbic acid (AA) is reported to inhibit the formation
of reactive oxygen species, sensitize cancer cells, and induce apoptosis.
In this context, AA, GO, and AA-GO were loaded into niosomal nanovesicles
to ameliorate the physicochemical properties of GO and improve its
cytotoxic effects using the thin-film hydration technique. The prepared
nanovesicles had a spherical shape with average diameters ranging
from 200 to 300 nm and exhibited outstanding surface negative charges,
high entrapment efficiencies, and a controlled sustained release over
72 h. Entrapping AA and GO in niosomes resulted in a lower IC50 value than free AA and GO when tested on MCF-7 breast cancer
cells. In addition, flow cytometry analysis showed higher apoptotic
cells in the late apoptotic stage upon treating the MCF-7 breast cancer
cells with AA-GO niosomal vesicles compared to treatments with free
AA, free GO, and AA or GO loaded into niosomal nanovesicles. Assessing
the antioxidant effect of the free drugs and loaded niosomal nanovesicles
showed enhanced antioxidant activity of AA-GO niosomal vesicles. These
findings suggest the AA-GO niosomal vesicles as a potential treatment
strategy against breast cancer, possibly through scavenging free radicals.